Although MMP7 involvement in PDAC initiation and progression has been reported (Fukuda et al, 2011), our results showing high MMP7 plasma levels in association with early tumor progression in PDAC‐GEM models and in patients with PDAC at stages IA, IB, and IIA confirm its value as a potential early diagnostic biomarker. The gene discussed is MMP7; the disease is neoplasm.